Skip to content
    AVIR stock page

    Atea Pharmaceuticals, Inc.

    AVIR · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 12, 2026

      Atea Pharmaceuticals Q2 FY26 — Positive Phase 3 C-Beyond Results and Pipeline Advancement

      Read the brief

    Browse all US companies on the earnings-call register.